血管扩张剂负荷SPECT中房室传导阻滞的发生率:一项荟萃分析
该荟萃分析检索SCOPUS至2016年3月,纳入34项研究共22957例患者,评估腺苷或瑞加腺苷负荷SPECT-MPI时新发房室传导阻滞的发生率。总体房室传导阻滞估计发生率为3.81%(95%CI 1.99%-6.19%),高度房室传导阻滞为1.93%(95%CI 0.77%-3.59%)。腺苷组总体及高度房室传导阻滞发生率均高于瑞加腺苷组(P<.001)。
要点
- 血管扩张剂负荷试验中房室传导阻滞发生率约4%。
- 腺苷组总体房室传导阻滞发生率高于瑞加腺苷组(P<.001)。
- 腺苷组高度房室传导阻滞发生率亦高于瑞加腺苷组(P<.001)。
核心结论
- 血管扩张剂负荷试验中约4%的患者出现房室传导阻滞。
- 腺苷较瑞加腺苷更常出现总体及高度房室传导阻滞。
研究设计与样本
- 荟萃分析,全面检索SCOPUS数据库自建库至2016年3月。
- 纳入使用腺苷和/或瑞加腺苷行SPECT-MPI、报告房室传导阻滞发生率、至少10例患者的研究。
- 共 pooled 34项研究,合计22957例患者;21项研究使用腺苷,15项使用瑞加腺苷,2项两者均使用。
主要发现
- 总体房室传导阻滞估计发生率为3.81%(95%CI 1.99%-6.19%)。
- 高度房室传导阻滞估计发生率为1.93%(95%CI 0.77%-3.59%)。
- 腺苷组总体房室传导阻滞发生率为8.58%(95%CI 5.55%-12.21%),瑞加腺苷组为0.30%(95%CI 0.04%-0.82%),P<.001。
- 腺苷组高度房室传导阻滞发生率为5.21%(95%CI 2.81%-8.30%),瑞加腺苷组为0.05%(95%CI <.001%-0.19%),P<.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adenosine or regadenoson are often used with pharmacologic stress testing. Adenosine may trigger atrioventricular block (AVB). Despite its higher selectivity, regadenoson has also been associated with AVB. We studied the incidence of de novo AVB with these agents. METHODS: A comprehensive search of SCOPUS was performed from inception to March 2016. Studies of at least 10 patients, using adenosine and/or regadenoson with SPECT-MPI, reporting rates of AVB were selected for further review. RESULTS: Thirty four studies were pooled including 22,957 patients. Adenosine was used in 21 studies and regadenoson in 15. Both were administered in two studies. The estimated incidence of overall and high-grade AVB was 3.81% (95% CI 1.99%-6.19%) and 1.93% (95% CI 0.77%-3.59%), respectively. The incidence of AVB (8.58%; 95% CI 5.55%-12.21% vs 0.30%; 95% CI 0.04%-0.82%, respectively, P < .001) and high-grade AVB (5.21%; 95% CI 2.81%-8.30% vs 0.05%; 95% CI < .001%-0.19% respectively, P < .001) were higher with adenosine compared to regadenoson. CONCLUSION: AVB is seen in about 4% of patients undergoing vasodilator stress test. Both overall and high-grade AVB are more frequent with adenosine compared to regadenoson.
引用
- Andrikopoulou E, Morgan CJ, Brice L, et al. Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis. J Nucl Cardiol. 2017. PMID: 29043556. doi:10.1007/s12350-017-1081-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。